Breast cancer: estrogens as carcinogens
Abstract
The major known risk factors for breast cancer are associated with a prolonged exposure to increased levels of estrogens and their reactive metabolites. The mechanisms through which estrogens contribute to the carcinogenic process are complex. Evidence suggests the involvement of estrogen-receptor-mediated signalling which increases cell proliferation of mammary tissue. Furthermore, the metabolism of estrogens leads to the production of reactive metabolites, which exert genotoxic effects. Considerable inter-individual variability in the metabolic pathways of estrogens is attributed to polymorphisms in the genes encoding for enzymes involved in estrogen metabolism. These person-to-person differences define subpopulations of women with different lifetime exposure to estrogens and/or estrogen metabolites. Assessing these genetic differences is therefore relevant as it may help to identify postmenopausal women who are particularly susceptible to breast cancer if exposed to exogenous hormones by hormone replacement therapy.Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.